Cargando…
Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8(+) T cells in pancreatic cancer
We investigate how myeloid subsets differentially shape immunity to pancreatic ductal adenocarcinoma (PDA). We show that tumor antigenicity sculpts myeloid cell composition and functionality. Antigenicity promotes accumulation of type 1 dendritic cells (cDC1), which is driven by Xcr1 signaling, and...
Autores principales: | Burrack, Adam L., Schmiechen, Zoe C., Patterson, Michael T., Miller, Ebony A., Spartz, Ellen J., Rollins, Meagan R., Raynor, Jackson F., Mitchell, Jason S., Kaisho, Tsuneyasu, Fife, Brian T., Stromnes, Ingunn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057584/ https://www.ncbi.nlm.nih.gov/pubmed/35393950 http://dx.doi.org/10.1172/jci.insight.151593 |
Ejemplares similares
-
Germline T cell receptor exchange results in physiological T cell development and function
por: Rollins, Meagan R., et al.
Publicado: (2023) -
Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fate
por: Burrack, Adam L., et al.
Publicado: (2022) -
Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma
por: Burrack, Adam L., et al.
Publicado: (2019) -
Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma
por: Patterson, Michael T., et al.
Publicado: (2023) -
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
por: Schmiechen, Zoe C., et al.
Publicado: (2021)